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Background: Carcinoma of unknown primary site (CUP) is said to account for approximately 3 to 5% of all
carcinomas. However, an isolated lesion in the abdominal cavity is rare, and there are no reports describing
associated abscess formation.
Case presentation: A 76-year-old woman had consulted a previous physician complaining of fever and right lower
quadrant abdominal pain. Enhanced computed tomography (CT) showed an abscess formation around the cecum.
She was treated conservatively with antibiotics, but the symptoms relapsed and she consulted our hospital.
Enhanced CT showed a persistent abscess, a tumorous lesion in the mesentery and right hydronephrosis. Because
malignancy could not be ruled out, surgical treatment was selected. At laparotomy, encapsulated abscesses were
found on the mesenteric side and outside of the ileocecal region. When we raised the ileocecal region, a tumor
was found to be fixed to the right ureter, and there was leakage of white, solid tumor content. This tumor content
was submitted to intraoperative frozen section diagnosis which revealed a carcinoma. Ileocecal resection with D3
lymph node dissection and retroperitoneal tumor resection was thus performed. There were no abnormal findings
in the uterus and adnexa, nor any evidence of peritoneal dissemination. We regarded this case as an incomplete
resection and chemotherapy with paclitaxel and carboplatin was administered. The patient has remained alive and
disease-free for almost one year since the primary operation.
Conclusion: We described a case with mesenteric CUP discovered during surgery for an intra-abdominal abscess. It
is necessary to pay attention to treatment-resistant intraperitoneal abscesses as they may accompany a tumor.
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Carcinoma of unknown primary site (CUP) is defined as
the presence of metastatic cancer in the absence of an
identifiable primary tumor site, even after thorough cli-
nical examination and diagnostic studies. CUP accounts
for approximately 3 to 5% of all malignancies, and is
thus not particularly rare [1,2]. However, CUPs are a
heterogeneous group of malignant neoplasms with dif-
ferent biological characteristics. In CUP cases, finding
an isolated lesion in the abdominal cavity is rare, and* Correspondence: yamagay-tky@umin.ac.jp
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reproduction in any medium, provided the orassociated abscess formation is extremely rare. Herein,
we report a CUP case in which a tumor was discovered
during surgery for a treatment-resistant intra-abdominal
abscess.Case presentation
The patient was a 76-year-old woman who had a history
of surgery for papillary thyroid cancer and cesarean sec-
tion with uterus bicornis.
She had consulted a previous physician complaining
of fever and right lower quadrant abdominal pain. A
marked inflammatory reaction was observed and en-
hanced computed tomography (CT) showed abscess for-
mation around the cecum. An intra-abdominal abscessral Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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with antibiotics, but her symptoms relapsed after dis-
charge and she was referred to our hospital. The inflam-
matory reaction showed exacerbation and cancer antigen
125 (CA125) was mildly elevated (78 U/mL). Enhanced
CT was performed again and showed a persistent abscess,
a tumorous lesion in the mesentery and right hydrone-
phrosis (Figure 1). Because malignancy could not be ruled
out, surgical treatment was selected.
At laparotomy, there were no ascites but encapsula-
ted abscesses were present on the mesenteric side and
outside of the ileocecal region (Figure 2a,b). When we
raised the ileocecal region, a tumor was found to be
fixed to the right ureter and there was leakage of white,
solid tumor content (Figure 2c). This tumor content was
submitted to intraoperative frozen section diagnosis,
which demonstrated a ‘carcinoma’. Also, enlarged lymph
nodes were observed along the ileocolic artery. For the
above reasons, we performed ileocecal resection with D3
lymph node Dissection. A ureteral stent was then in-
serted into the right ureter, and the tumor was separated
and removed from the ureter with scissors (Figure 2d).
The ureteral stent was easily inserted without resis-
tance and urine cytology was negative for carcinoma.
After tumor removal, we searched the abdominal ca-
vity thoroughly, but there were no abnormalities of
the uterus and adnexa, nor any evidence of periton-
eal dissemination.
The pathological diagnosis was poorly differentiated
carcinoma, but there were no changes involving theFigure 1 Re-examination by enhanced computed tomography (CT) sc
the mesentery (b), and persistent encapsulated abscesses on the mesentermucosal surface of the cecum or the terminal ileum
(Figure 3). The mesenteric lymph nodes were free of
metastasis. Hematoxylin-eosin (HE) staining showed
findings of poorly differentiated carcinoma, and alcian
blue (AB) staining showed moderate production of
mucin accompanied by a partial ductal structure. Im-
munohistochemistry showed the tumor to be positive for
AE1/AE3 (pancytokeratin), cytokeratin(CK)7, CK34βE12
(about 20% of tumor) and Wilms tumor gene 1 (WT-1),
with nonspecific reactions for CK5/6, p63, carcino-
embryonic antigen (CEA), estrogen receptor (ER) and
vimentin, while CK20, thyroid transcription factor 1
(TTF-1), caudal type homeobox 2 (CDX2), gross cys-
tic disease fluid protein-15 (GCDFP-15), calretinin,
D2-40 and CD10 were negative (Figure 4). No patho-
gen was detected in bacterial culture of the pus. After sur-
gery, esophagogastroduodenoscopy and colonoscopy were
conducted, and no gastrointestinal tract lesions were
observed. Gynecologic and transvaginal ultrasonogra-
phy (US) examinations revealed no abnormal findings.
Positron emission tomography (PET) showed no ab-
normal uptake.
Because the tumor content had leaked into the abdo-
minal cavity, we regarded this case as having undergone
incomplete resection and six courses of chemotherapy
with paclitaxel (PTX, 220 mg/body at day one) and car-
boplatin (CBDCA, 360 mg/body at day one) were ad-
ministered at intervals of four weeks. The patient has
remained well and disease-free for almost one year, to
date, since the primary operation.an. The CT scan shows right hydronephrosis (a), a tumorous lesion in
ic side (c) and on the outside (d) of the ileocecal region.
Figure 2 Intraoperative findings. Encapsulated abscesses can be seen on the mesenteric side (a) and outside of the ileocecal region (b). When
we raised the ileocecal region, a tumor was found to be fixed to the right ureter (c). A ureteral stent was inserted into the right ureter; the tumor
was then separated and removed from the ureter (d).
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CUP accounts for approximately 3 to 5% of all malig-
nancies. Finding CUP as an isolated lesion in the ab-
dominal cavity is rare and there are no reports, to our
knowledge, of cases with abscess formation. This is thus
the first report of CUP discovered during surgery for an
intraperitoneal abscess.
Histopathological examination, especially the immuno-
histochemical approach, is important for identifying theFigure 3 Macroscopic findings of the tumor and ileocecal
lesion. No changes involving the mucosal surface of the cecum or
the terminal ileum were detected.primary lesion in patients with CUP [1]. In our present
case, AE1/AE3 was positive; AB staining showed moder-
ate production of mucin accompanied by a partial ductal
structure; and squamous cell markers CK34βE12, CK5/6
and p63, were also slightly positive. However, HE stain-
ing showed findings of carcinoma with low differen-
tiation overall, indicating a final diagnosis of ‘poorly
differentiated carcinoma’.
Efforts were made to identify the primary tumor. The
gastrointestinal tract was negative because CDX-2 was
negative. The patient had a past history of papillary thy-
roid cancer but TTF-1 was negative and the nuclear
findings were also inconsistent with thyroid cancer re-
currence. Furthermore, the possibility of primary ovarian
cancer was considered based on the CK7 positive, CK20
negative, calretinin negative, WT-1 positive, CEA non-
specific and ER nonspecific findings. However, intraopera-
tive findings and postoperative gynecological examination,
transvaginal US, and PET revealed no abnormalities and
there were no findings indicating a primary ovarian
tumor.
CUPs are a heterogeneous group of malignant neo-
plasms with different biological characteristics. Our pa-
tient’s age and pelvic tumor with an increased CA125
value suggested so-called ‘serous papillary peritoneal car-
cinomatosis’ [3]. However, findings indicating that the
tumor ‘was not adenocarcinoma’, ‘was confined to the
retroperitoneal cavity with no exposure to the abdominal
cavity’ and ‘was not accompanied by peritoneal dis-
semination’ were also noted in the pathological report.
Figure 4 Histological and immunohistochemical findings of the tumor. Hematoxylin-eosin (HE) staining reveals poorly differentiated carcinoma
(a). Alcian blue (AB) staining showed moderate production of mucin accompanied by a partial ductal structure (b). Immunohistochemistry was partially
positive for CK34βE12 (about 20% of tumor) (c), positive for AE1/AE3 (d), negative for CDX2 (e), and negative for TTF-1 (f).
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papillary peritoneal carcinomatosis.
In addition, abscess formation was observed in this
case. The tumor was in contact with the gastrointestinal
tract, but did not penetrate the digestive tract. Culture
of the pus yielded no infectious organisms. For these
reasons, it was suggested that this tumor was not gastro-
intestinal in origin and that the abscesses had formed
due to necrosis of the tumor. From the location of the
abscesses, cecal diverticulitis had been suspected by the
previous physician, and conservative treatment with an-
tibiotics had been selected. However, the abscesses were
unaffected by this treatment. When she consulted our
department, re-examination by CT raised suspicion of a
tumorous lesion and surgical management was chosen,
finally providing a definitive diagnosis. It is necessary to
pay attention to treatment-resistant intraperitoneal ab-
scesses as they may accompany a tumor.
With CUP, as its name suggests, a ‘metastatic’ carcinoma
with an unknown primary site, the prognosis is generally
poor and chemotherapy has been the basis of treat-
ment. Platinum-based or platinum-taxane combinationchemotherapy is common [4-6]. Depending on the char-
acteristics and the location of the tumor, multimodal
therapy combining radiation, cytoreductive surgery and
chemotherapy is sometimes performed. In this case, be-
cause abscesses were also present and the tumor was
confined to the retroperitoneum, we performed sur-
gery followed by PTX and CBDCA combined chemo-
therapy. The patient has remained recurrence free for
one year, to date, since the initial operation.
Conclusion
We have presented a case with mesenteric poorly dif-
ferentiated carcinoma of unknown primary site with
abscess formation. It is necessary to pay attention to
treatment-resistant intraperitoneal abscesses because
of their possible association with malignant tumors.
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